Otofarma S.p.A. Logo

Otofarma S.p.A.

Provides tailored hearing solutions and remote diagnostics through a partner pharmacy network.

OTO | Euronext Growth

Overview

Corporate Details

ISIN(s):
IT0005663361
LEI:
815600FED560ACA5D783
Country:
Italy
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Otofarma S.p.A. is an Italian company that specializes in the design, manufacture, and marketing of custom hearing aids and related accessories. The company provides personalized otoacoustic medical devices, including in-the-ear (Endoauricular) and behind-the-ear (Retroauricular) models, to address hearing loss. A key part of its service offering is Teleaudiology, a telemedicine platform that facilitates remote otoscopic and audiometric examinations through a network of partner pharmacies. This allows specialists to prescribe and create precisely tailored hearing solutions for patients based on detailed diagnostic data. The company emphasizes its focus on comfort, discretion, and delivering a natural sound experience for its users.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-15 08:00
Regulatory News Service
OTOFARMA: NUOVO STABILIMENTO A MILANO PER RAFFORZARE LA CAPACITÀ PRODUTTIVA
Italian 302.4 KB
2025-10-15 08:00
Regulatory News Service
OTOFARMA: NEW PLANT IN MILAN TO BOOST PRODUCTION CAPACITY
English 316.5 KB
2025-10-01 09:18
Earnings Release
OTOFARMA: BOARD OF DIRECTORS APPROVES HALF-YEAR REPORT AND PRO FORMA CONSOLIDAT…
English 496.1 KB
2025-10-01 08:34
Earnings Release
OTOFARMA: CDA APPROVA LA RELAZIONE SEMESTRALE E I PROSPETTI CONSOLIDATI PRO-FOR…
Italian 548.2 KB
2025-09-08 17:49
Share Issue/Capital Change
OTOFARMA: announcement of change in share capital following full exercise of gr…
English 353.3 KB
2025-09-08 17:47
Share Issue/Capital Change
OTOFARMA: comunicazione di avvenuta variazione del capitale sociale a seguito d…
Italian 355.3 KB
2025-09-05 18:03
Director's Dealing
Internal Dealing
Italian 88.5 KB
2025-09-02 18:17
Share Issue/Capital Change
OTOFARMA: full exercise of the Greenshoe Option
English 320.7 KB
2025-09-02 18:14
Share Issue/Capital Change
OTOFARMA: esercizio integrale dell’opzione greenshoe
Italian 347.4 KB

Automate Your Workflow. Get a real-time feed of all Otofarma S.p.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Otofarma S.p.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Otofarma S.p.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Convatec Group PLC Logo
Develops medical solutions for chronic wound, ostomy, continence, and infusion care globally.
United Kingdom
CTEC
COOPER COMPANIES, INC. Logo
A medical device company providing contact lenses and women's health & fertility solutions.
United States of America
COO
Corentec Co., Ltd. Logo
Global developer and manufacturer of advanced orthopedic implants and artificial joints.
South Korea
104540
CREATE MEDIC CO.,LTD. Logo
Manufactures silicone medical supplies like catheters and tubes for global healthcare.
Japan
5187
CREO MEDICAL GROUP PLC Logo
Develops advanced energy electrosurgical devices for minimally invasive therapeutic endoscopy.
United Kingdom
CREO
Develops implantable tech for localized chemotherapy delivery directly into solid tumors.
Virgin Islands (British)
CRTX
CS Medica A/S Logo
Develops patented, CBD-infused medical devices for pain, autoimmune, and stress relief.
Denmark
CSMED
Cytogen, Inc. Logo
Developing liquid biopsy technology to isolate tumor cells for cancer diagnostics and research.
South Korea
217330
Cytori Cell Research Institute,Inc. Logo
Develops devices and cell therapies using a patient's fat tissue to repair injury and treat disease.
Japan
3750
Cytosorbents Corp Logo
Specializing in blood purification therapies for critical care to treat life-threatening conditions.
United States of America
CTSO

Talk to a Data Expert

Have a question? We'll get back to you promptly.